Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: Medifast is engaged in the production, distribution, and sale of weight management and disease management products. Operations are conducted through three primary channels: Medifast Direct (direct-to-consumer), Take Shape for Life (direct selling via health coaches), and Medifast Weight Control Centers (corporate and franchise clinics).
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $60,585,000 | $34,605,000 |
| Gross Profit | $45,768,000 | $25,626,000 |
| Gross Margin | 75.5% | 74.1% |
| Operating Income | $8,201,000 | $4,016,000 |
| Net Income | $4,901,000 | $2,485,000 |
| Diluted EPS | $0.33 | $0.17 |
| Cash and Equivalents (End of Period) | $20,814,000 | $5,445,000 |
| Operating Cash Flow | $14,129,000 | $5,362,000 |
| Total Debt (Current + Long-term) | $6,041,000 | Filing text does not provide a clear consolidated prior period debt total |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 75% year-over-year, driven primarily by the Take Shape for Life channel (94% increase) and the Weight Control Centers (75% increase).
- Profitability: Net income nearly doubled (97% increase) to $4.9 million. Operating margin improved to 13.5% from 11.6%.
- Liquidity: Cash and cash equivalents more than doubled from $10.6 million to $20.8 million, supported by strong operating cash flow of $14.1 million.
- Accounting Change: Shipping revenue, previously netted against shipping expenses in Cost of Sales, is now recognized as revenue. This contributed to the reported revenue increase ($2.1 million in Q1 2010 vs. $0.9 million in Q1 2009).
- Expense Growth: Selling, general, and administrative (SG&A) expenses rose 74% to $37.6 million, largely due to variable commissions from Take Shape for Life sales growth and increased advertising spend.
Guidance, Outlook, and Risks
- Outlook: Management anticipates opening an additional 13-15 corporately owned Weight Control Centers in 2010. The company expects an effective tax rate of approximately 39-40% for the full year 2010.
- Seasonality: Historically, January and February are strong "diet season" months, while November/December are weaker. Management notes that seasonality is decreasing as consumers view the products as year-round health solutions.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2010, due to a material weakness in the tax provision calculation process. Remediation includes hiring an in-house CPA and engaging an outside tax advisor for quarterly reviews.
- Legal Proceedings: Medifast filed a civil complaint seeking at least $270 million in damages against Barry Minkow and others for defamation and alleged market manipulation.
- Market Risk: The company has $6.0 million in variable-rate debt. A 100 basis point increase in LIBOR would increase interest expense by approximately $60,000 annually.
Investor Verification Checklist
- Take Shape for Life Sustainability: Verify the retention rate of the 7,100 active health coaches (up 78% YoY) and the sustainability of the 94% revenue growth in this channel.
- Internal Control Remediation: Monitor the effectiveness of the new tax provision review procedures to ensure the material weakness is resolved in future filings.
- Legal Exposure: Track the status of the $270 million defamation lawsuit against Barry Minkow and potential impacts on brand reputation or stock price.
- Capital Allocation: Review the planned executive stock sales (approx. 200,000 shares by executives and 133,000 by the Chairman's wife) and the status of the share repurchase program (365,000 shares remaining).
- Inventory Levels: Inventory increased by $2.4 million to $13.6 million; verify that this buildup aligns with sales velocity and does not indicate obsolescence risk.